Introduction
Hepatoid adenocarcinoma is a rare cancer, defined by its morphological and functional differentiation similar to hepatocellular carcinoma 1 . The most commonly affected organ is the stomach (63%) but it may affect others, such as ovary (10%), lung (5%), bladder (4%), pancreas (4%) and uterus (4%) 2 . Hepatoid adenocarcinoma of the lung is an extremely rare form, with only 20 cases described 3 . The pathophysiology is not yet fully described, but during embryonic development, the lung, liver and stomach, all derive from the foregut. Probably, due to changes in differentiation, adenocarcinoma cells from specific organs, such as the lung, differentiate into liver cells 1 . Hepatoid adenocarcinoma was first described in 1990 by Ishikura et al 4 . Five cases of hepatoid adenocarcinoma of the lung with alpha-fetoprotein expression (AFP) were described in this study and 2 criteria were created for its diagnosis: a. Typical acinar or papillary adenocarcinoma, b. A component resembling hepatocellular carcinoma and expressing AFP 2, 4 . These criteria have been updated, namely the production of AFP by neoplasia, given the use of almost certainly more specific immunohistochemical markers (such as Hep-PAR-1). However, given the scarce number of diagnoses performed so far, a ultimate conclusion has not yet been reached 5 .
Case description
Eighty-year-old male, with clinical history of colon cancer resected in 1999, a former smoker with a 60 pack-year history, without chronic medication. The patient was referred to pulmonology consultation for suspected Chronic Obstructive Pulmonary Disease. In the follow-up, it was required a thorax CT which presented: "In the mediastinum two ganglionic agglomerates are evident, one located in the right para-tracheal region, presenting some enlarged ganglia, considering the limitation of the confluence, apparently 25x16mm. The other cluster in the right hilar region, with smaller ganglia (...). "; in the lung parenchyma there are no relevant structural changes... In the pancreas... nodular image with about 11mm, hypodense but with poorly defined contours, with focal point of peripheral calcification... it is suggested a confrontation with MRI study ". In order to characterize the pancreatic nodule, abdominal MRI was requested. It described the pancreatic nodule as having a probable cystic nature, adding the following change: "During the study, we observed an expansive infiltration in the right bronchial tree up to the emergence of the right basal pyramid, which conditions enlargement of the B spur, procidence of the anterior wall of A and C, conditioning concentric stenosis, particularly of B and C, allowing the passage of the bronchofibroscope". Bronchial biopsy revealed: "... infiltration of the chorion by large, isolatedly arranged neoplastic cells with irregular, bulky nuclei with one or more prominent nucleoli. These fragments present a lymphoplasmacytic and granulocytic inflammatory infiltrate of mild to moderate intensity... Immunohistochemical study: Immunopositivity for CAM5.2 and also for cytokeratin 34 Beta E12, of lower intensity. Granular cytoplasmic positivity for HepPar 1. Remaining performed markers (cytokeratin 20, p63 and TTF1) were negative. The morphology and immunohistochemical profile of this tumor are similar to the bone metastasis. Conclusion: Bronchial involvement by hepatoid-type carcinoma. " ( fig. 2 ) This biopsy led to the ultimate diagnosis of hepatoid adenocarcinoma of the lung. During the ulterior month, the patient presented an important deterioration of his condition, and died 3 months after the diagnosis.
Discussion
Hepatoid adenocarcinoma of the lung is a rare entity, and given its wide-ranging presentation forms, its diagnosis and treatment has been difficult, only made easy by immunohistochemical analysis Several studies have shown this tumor ablity to produce albumin, ferritin, transferrin and alpha-fetoprotein, commonly produced substances by liver cells 1 . Patients with this kind of cancer are usually male and smokers, being usually diagnosed at an advanced stage of the disease 1, 6 . Recently, the diagnostic criteria for this cancer included the presence of elevated levels of alpha-fetoprotein. However, quite a few studies have shown that AFP is not specific for hepatoid adenocarcinoma of the lung, being more frequently associated to hepatocellular The expression of alpha-fetoprotein is not mandatory for the diagnosis, as long as other immunohistochemical markers of hepatic differentiation are expressed 2, 6 . Therefore, the presented case meets criteria for the diagnosis of hepatoid adenocarcinoma of the lung. Even though not expressing AFP, it reveals histological characteristics of hepatoid carcinoma and positivity for the hepatic cell specific marker HepPar 1. On the other hand, the study carried out during hospitalization made it possible to exclude hepatic metastases. The prognosis for hepatoid adenocarcinoma of the lung is generally gloomy, with an average life expectancy ranging from 7 months to 7 years in patients undergoing surgery. There is however a description of a 9-year survival case 6 . Bibliography Fig 2. Biopsy specimen revealed bronchial mucosa with extensive malpighian metaplasia. Chorion infiltration by neoplastic cells was observed focally. This cells were polygonal with large amount of eosinophilic cytoplasm and central hyperchromatic nuclei with prominent nucleoli, resembling hepatocellular carcinoma.
